Prevention of central line associated bloodstream infections in critical care units Simon Li a and Matthew J. Bizzarro b
|
|
- Florence Gilmore
- 5 years ago
- Views:
Transcription
1 Prevention of central line associated bloodstream infections in critical care units Simon Li a and Matthew J. Bizzarro b a Department of Pediatrics, Westchester Medical Center, Valhalla, New York and b Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA Correspondence to Simon Li, MD, Department of Pediatric Critical Care, Maria Fareri Children s Hospital at Westchester Medical Center, 100 Woods Road, Valhalla, NY 10595, USA Tel: ; lis@wcmc.com Current Opinion in Pediatrics 2011, 23:85 90 Purpose of review Central line associated bloodstream infections (CLABSIs) are a common source of morbidity and mortality in neonatal and pediatric intensive care units. Successful preventive strategies have recently been reported which have resulted in significant reductions in CLABSIs and their associated adverse outcomes. Recent findings Current surveillance data indicate a recent decline in reported CLABSI rates, likely secondary to changes in diagnostic criteria and improvements in central line care. Recent pilot randomized trials in the neonatal intensive care unit population have assessed the safety and efficacy of chlorhexidine gluconate for cutaneous antisepsis and silver alginate-impregnated dressings. No significant reductions in CLABSIs have been noted with the use of either. The greatest success has come with implementation of evidence-based catheter care bundles, which have been shown in individual units and collaborative critical care networks to significantly reduce CLABSI rates. Summary CLABSIs remain a significant problem in neonatal and pediatric critical care units, but implementation of catheter care bundles can significantly reduce rates of these infections. The safety and efficacy of chlorhexidine gluconate, silver alginate, and antibiotic-coated catheters need to be assessed via large, multicenter trials. Creation of collaborative networks may facilitate this goal. Keywords central venous catheterization, evidence-based medicine, healthcare-associated infections, intensive care unit, neonatal, pediatrics Curr Opin Pediatr 23:85 90 ß 2011 Wolters Kluwer Health Lippincott Williams & Wilkins Introduction Central line associated bloodstream infections (CLAB- SIs) are common in the neonatal and pediatric intensive care unit (NICU and PICU, respectively) populations. CLABSI can significantly increase medical costs, morbidity, and mortality [1 4]. These associated outcomes, combined with mandates in public reporting and proposals from insurance providers to withhold payment for healthcare-associated infections (HAIs) [5], have resulted in efforts among critical care units to curtail these infections as well as increase research efforts to improve central line care. In this review we focus on current issues surrounding the definition of CLABSI, recent data on improved methods for central line management, and successful approaches to preventing CLABSI among individual and collaborative NICUs and PICUs. Defining a central line associated bloodstream infection A CLABSI is defined as a laboratory-confirmed bloodstream infection (LCBI) without another identifiable source that occurs with a central line in place at the time of, or within 48 h before, the onset of infection [6]. Accurately defining an LCBI can be a challenge. To maintain consistency in public reporting and to assist in infection control, the National Healthcare Safety Network (NHSN) has devised and published definitions for common HAIs including CLABSIs [7,8]. In 2008, these definitions were modified with a major change involving more stringent criteria for the diagnosis of common skin contaminant-related LCBI [8]. The prior definition stated that, in addition to the presence of signs and symptoms of infection, a common skin contaminant had to be cultured from two or more blood cultures drawn on separate occasions or from one blood culture after which appropriate antimicrobial therapy is instituted [7]. The definition now only states that, in addition to signs and symptoms of infection, there must be two or more positive blood cultures to meet criteria [8]. The modification, in practice, has presented some pitfalls. Obtaining two blood cultures of adequate volume in critically ill neonates and children can be difficult and can thereby impact diagnosis [i.e. if only one culture is ß 2011 Wolters Kluwer Health Lippincott Williams & Wilkins DOI: /MOP.0b013e328341d1da
2 86 Infectious diseases and immunization obtained and is positive for coagulase-negative staphylococci (CoNS), criteria are technically not met]. Furthermore, many clinicians would likely institute antistaphylococcal therapy even if they were only able to obtain a single blood culture given the potential impact of delaying appropriate antimicrobial coverage. This would potentially make the results of subsequent blood cultures unreliable. Given that CoNS make up the majority of pathogens responsible for CLABSI [9], the potential now for under-reporting must be considered. In 2007, using data from 2006 and the prior definition for an LCBI, the NHSN reported overall NICU and PICU-related CLABSI rates of 4.3 and 5.3 per 1000 central line days, respectively [10]. In 2009, using data from 2006 through 2008 and the new definition, they reported a benchmark CLABSI rate of 2.9 per 1000 for both NICU and PICU patients [11 ]. Whereas some of the decline in CLABSI surveillance rates may be due to improvements in central line care, the definition change is likely to have played a role. With so much pressure and emphasis now on getting to zero, accurate reporting of benchmark data has become critical and under-reporting potentially problematic. Furthermore, it remains to be determined whether this change has had any impact on practice. In particular, has the need for two positive blood cultures altered the clinician s perception of what is or is not a true infection and thereby affected the continued problem of antimicrobial over-exposure in the ICU? Cutaneous antisepsis and chlorhexidine gluconate The majority of CLABSIs are believed to be preventable. Considerable efforts have focused on improving and developing novel techniques for central line placement and management (Table 1). Selection of an appropriate cutaneous antiseptic is one crucial aspect of CLABSI prevention [6]. Guidelines for adult and pediatric populations recommend the use of chlorhexidine gluconate (CHG) over povidone iodine, and most PICUs have adopted this practice. However, controversy still exists as to its safety and efficacy in neonates [6]. Although CHG may reduce bacterial colonization as compared with povidone iodine, its use in the NICU has not been shown to reduce the risk of CLABSI [12]. Some data suggest that 2% CHG exposure may result in local skin reactions [13,14]. As a result of this and the concern for systemic absorption, the Federal Drug Administration (FDA) has not approved CHG for cutaneous use in infants below 2 months of age. In an effort to further explore this issue, a pilot-randomized trial was conducted in five NICUs to assess systemic absorption of CHG and to compare rates of contact dermatitis with the use of an alcohol-based 2% CHG vs. 10% povidone iodine for cutaneous antisepsis in Key points CLABSI impacts on morbidity, mortality, and healthcare cost in ICUs. The establishment of a uniform definition of CLABSI is very helpful for research but may not be as useful for the clinical setting. The most effective current strategy for decreasing CLABSI rates is the use of evidence-based central line bundles. Further research is needed to fully evaluate antimicrobial coated catheters and antimicrobial dressings in children. Chlorhexidine gluconate application in neonates for the prevention of CLABSI should be further evaluated to fully understand its risks and benefits. infants requiring a peripherally inserted central catheter (PICC) [15 ]. Enrollment was limited to infants more than 1500 g and above 7 days and below 2 months of age. Twenty-four infants were enrolled in each group. No cases of severe dermatitis were observed. Ten neonates had serum CHG levels evaluated, with measurable amounts detected in seven. Serum concentrations of CHG were noted to increase with the number of cutaneous applications. No significant differences were noted between groups with respect to rates of bloodstream infection (BSI) [15 ]. Despite evidence of systemic absorption and the fact that the FDA does not approve its cutaneous use in infants below 2 months of age, CHG is still utilized in this population, with some reporting safety and efficacy with its intermittent application [14]. In order to definitively assess CHG use in the neonates in both the NICU and PICU populations, a large, randomized controlled trial of infants below 2 months of age, with analysis of subgroups including the extremely low birth weight population, is needed. In the meantime, lack of data to support its efficacy and concerns regarding risks of systemic absorption and what effect it may have on the neonate remain a deterrent to its use. Catheter site care Proper cathether site care is vital to CLABSI prevention, as contamination of the catheter hub is believed the most common source of these infections [16,17 ]. The NICU at Westchester Medical Center conducted a recent investigation aimed at evaluating the impact of a new approach to catheter hub care [18]. An educational program was developed which included reinforcement of hand hygiene, the use of a hub care checklist, and 2% CHG in 70% isopropyl alcohol to scrub the catheter hub. Adherence to protocols resulted in a decrease in PICCrelated BSI from 23 infections per 1000 catheter-days to 12 [odds ratio (OR) 0.33, 95% confidence interval (CI)
3 Prevention of CLABSI in critical care units Li and Bizzarro 87 Table 1 Studies evaluating potential improvements in catheter insertion and maintenance Authors Study design Comparison Population Findings No dermatitis; measurable serum CHG levels in seven of 10; no significant difference in colonization or BSI Garland et al. [15 ] Randomized CHG vs. PI N ¼ 48; neonates >1500 g, >7 days, <60 days old Chlorhexidine gluconate for cutaneous antisepsis Significant reduction in colonization with CHG; no significant difference in BSI N ¼ 145; children 0 18 years; admitted postop. to a pediatric cardiac ICU Levy et al. [19] Randomized, controlled CHG sponge vs. clear occlusive Chlorhexidine gluconate impregnated dressings Measurable serum silver levels (below toxic); no skin reactions; no significant difference in CLABSI but lower rates in study group (6.7 vs per 1000 central line days) N ¼ 50; neonates g, >3 days old Silver-impregnated dressings Khattak et al. [20] Randomized, controlled Silver alginate vs. clear occlusive Study group of significantly lower birth weight (1330 vs g); no skin reactions noted; no significant difference in CLABSI N ¼ 118; NICU patients >3 days old Silver alginate vs. clear occlusive Hill et al. [21] Randomized, controlled (3 : 1 study: control) N ¼ 225; all PICU patients No significant difference in CLABSI; delay in onset of infection in treatment group (18 vs. 5 days) Antibiotic-coated catheters Chelliah et al. [22] Prospective, observational Minocycline rifampin coated vs. noncoated BSI, bloodstream infection; CHG, chlorhexidine gluconate; CLABSI, central line associated bloodstream infection; NICU, newborn intensive care unit; PI, povidone iodine; PICU, pediatric intensive care unit ] and umbilical catheter-related BSI from 15 to five infections per 1000 catheter-days (OR 0.47, 95% CI ). Cost savings from this initiative were determined to be between $ and $ [18]. In addition to catheter hub care, some recent investigations have evaluated antimicrobial impregnated dressings. As of the most recent Center for Disease Control and Prevention guidelines from 2002, no recommendations were made regarding the use of CHG or silver alginate-impregnated dressings in the NICU or PICU populations [6]. A recent well designed adult study from France with data from central line days showed that the use of CHG-impregnated sponges at the catheter insertion site significantly reduced their already low baseline rate of CLABSIs from 1.6 to 1.3 per 1000 central line days [23 ]. The authors did note an increase in severe contact dermatitis in patients using the CHG dressings. In the PICU population, there has only been one randomized trial conducted, in a pediatric cardiac intensive care unit in Israel, which evaluated the impact of CHGimpregnated dressings on CLABSI [19]. The investigation determined that there was less central line colonization with the use of these dressings, but the BSI rate did not differ significantly between study and control populations [19]. Of note, there were only seven BSIs identified in the 145 postoperative patients over the course of the study (three in the control group, four in the CHG), making it difficult to draw any definitive conclusions. In addition to CHG-impregnated dressings, the safety and efficacy of silver-infused PICC dressings has become an area of recent investigation [20,21]. Khattak et al. [20] conducted a pilot-randomized controlled trial to assess the use of topically applied silver alginate central line dressings in very low birth weight infants. Serum silver concentrations were collected and infection rates compared between the groups using silver alginate dressings and those using standard dressings. Twenty-five patients were enrolled in each group and, although serum silver concentrations were measurable, they were below what was considered to be toxic. No adverse skin reactions or impairment of hepatic or renal function were noted, and a nonstatistically significant reduction in CLABSI was observed in the treatment group as compared with controls (6.7 vs per 1000 line days) [20]. A second pilotrandomized controlled trial evaluated the effects of a sterile patch coated with ionic silver in NICU patients with a PICC [21]. No statistically significant differences were observed between groups with respect to CLABSIs (12.4% in the study group and 17.2% in controls) and no adverse reactions were observed [21]. Systemic absorption was not measured. These data seem to suggest that the use of silver-impregnated dressings may be well tolerated in the premature neonatal population but, as
4 88 Infectious diseases and immunization with the use of CHG, larger trials are needed to better assess their safety and efficacy before routine use can be advocated. Antimicrobial-coated catheters Data from adults seem to suggest that central lines impregnated with antimicrobials like minocycline and rifampin may reduce central line colonization and CLABSI [24,25]. These data led to recommendations for their use in adults with expected central line needs for more than 5 days [6]. In children below 3 kg, no antimicrobial-coated catheters are available, and there is little evidence to support their use in larger children. Data for use in the PICU population are limited to one prospective, observational study of 225 central lines [22]. Although no statistically significant difference was noted in the rate of CLABSIs with the use of minocyclin and rifampin-coated catheters as compared with uncoated catheters (7.5 vs. 8.6 per 1000 central line days), the investigators did note that the median time to infection was nearly three-fold longer in children who had an antibiotic-coated catheter. It is therefore possible that the use of antibiotic-coated catheters may delay onset of infection. This, coupled with prompt removal of catheters when no longer necessary, may result in reductions in CLABSI rates. However, further evidence is needed to understand the risks and benefits of antimicrobial-coated catheters in children. Catheter bundles Although approaches to individual aspects of central line management may be efficacious in reducing CLABSI, the greatest success has been reported with the use of catheter care bundles (Table 2). A bundle is a group of evidence-based interventions that, when implemented together, results in a better outcome than when executed individually [26 ]. In the NICU at Yale-New Haven Children s Hospital, we implemented a central line bundle based predominantly on the Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines [6] and aimed at reducing CLABSI and HAI among our hospitalized neonates [27]. A unit-wide educational effort was initiated which included a formalized, evidence-based training program for catheter placement and maintenance, implementation of daily discussions on patient care rounds regarding the continued need for a central line, and regular CLABSI surveillance and feedback to the staff [27]. Preinitiative and postinitiative data were compared and determined that CLABSI rates decreased significantly from 8.4 per 1000 central line days to 1.7 (rate difference: 6.7, 95% CI 9.0 to 4.5) and the overall rate of healthcare-associated BSI from 5.8 to 1.4 per 1000 patient days (rate difference 4.4, 95% CI 5.6 to 3.3) [27]. State-wide and national collaboratives aimed at reducing CLABSI have also been established. In 2006, 13 NICUs in California participated in an effort to reduce rate of CLABSI [28 ]. Interventions included organization of a leadership team in each NICU with physician, nursing, and infection control representatives and implementation of evidence-based best practices for hand hygiene and line placement and management. Conference calls were conducted and a team visited each NICU to assist in implementation of bundles. A 25% reduction in CLABSI Table 2 Best practices for central line insertion and maintenance Education, training, leadership Catheter insertion Catheter maintenance Catheter removal Surveillance Data from [6,17 ]. Assemble team with representatives from all aspects of central line care Designate team leaders (both physician and nursing) Conduct formalized education, training, and assessment of all personnel involved in central line insertion and care Create an insertion checklist Perform proper hand hygiene prior to all aspects of catheter insertion and care Utilize maximal sterile barrier precautions during insertion including cap, mask, sterile gown and sterile gloves, and large sterile drape to cover entirety of work area Use an assistant For children 2 months, utilize 2% chlorhexidine gluconate for cutaneous antisepsis. Scrub for 30 s for nonfemoral lines and 2 min for femoral lines and allow to air dry For children <2 months, utilize 10% povidone iodine and allow to dry for a minimum of 2 min Empower all staff to interrupt a nonemergent procedure if guidelines are not followed Minimize catheter entry Use a sterile, transparent dressing Change dressings when visibly damp, loosened, or soiled Use prepackaged dressing change kit and checklist Disinfect hub with alcohol or chlorhexidine gluconate Replace administration sets, including add-on devices, no more frequently than every 96 h unless they are soiled or suspected to be infected Replace tubing that is used to administer blood, blood products, or lipids within 24 h of initiating infusion Change caps no more often than 72 h Assess daily and remove when catheter is no longer needed Conduct regular surveillance of unit-based data utilizing standard definitions and provide periodic feedback to staff
5 Prevention of CLABSI in critical care units Li and Bizzarro 89 in all birth weight groups was observed as the overall rate of CLABSI declined from 4.3 to 3.2 infections per 1000 central line days [28 ]. Similarly, in 2007 the New York State Department of Health funded a collaborative between its regional perinatal centers aimed at devising an evidence-based initiative to reduce CLABSI [29 ]. Their objectives were to create a network to identify key performance criteria and to plan and implement quality improvement initiatives, to select a meaningful performance indicator, to identify sites with low CLABSI and to organize site visits, and to develop an evidence-based care bundle to reduce CLABSI [29 ]. Representatives from each regional perinatal centers participated in workshops aimed at addressing these aims [29 ]. When 6 months of postintervention data were analyzed, it was determined that, although NICU site was a major determinant of outcome, the use of central line maintenance checklists (part of their catheter care bundle) was associated with a reduction in CLABSI rates [30]. Individual PICUs and dedicated pediatric cardiac intensive care units have demonstrated similar success with the utilization of catheter care bundles [31,32]. Two large multicenter PICU collaborative efforts have been conducted to date [17,33]. Miller et al. [17 ] reported data from a long-term collaborative initiated in 2006 by the National Association of Children s Hospitals and Related Institutions (NACHRI). The collaborative incorporated 29 PICUs in a multicenter prospective study using historical data for comparison [17 ]. Their approach included selection of multidisciplinary team members at each site to lead the initiative, multiple centralized workshops, resource-intensive education and monitoring at the unit level, and funding to support the collaborative. Their major goal was a 50% reduction in CLABSI rates within 1 year through 90% adherence to insertion bundles and 70% adherence to maintenance bundles. What resulted was a significant reduction in CLABSI from 5.4 to 3.1 per 1000 central line days as well as 84% insertion and 82% maintenance adherence. Of note, the only significant predictor of CLABSI reduction was adherence to the maintenance, not the insertion, bundle [17 ]. As membership of NICU and PICU collaboratives like NACHRI continues to grow, data from these networks will hopefully assist in further assessing the efficacy and sustainability of current best practices. In addition, these large collaboratives present an opportunity to conduct large, multicenter randomized controlled trials which could definitely assess the safety and effectiveness of further approaches to pediatric catheter care, such as antibiotic-coated catheters and the use of CHG in neonates. Conclusion Central line associated bloodstream infections remain a major problem in neonatal and pediatric critical care units. Recent efforts have focused on improvements in materials as well as in techniques for cutaneous antisepsis and catheter site care. Growing interest and attention to preventing HAI has also initiated much needed funding for collaborative research aimed at better defining the problem and at further improving technology and strategies for central line care. To date, the most effective strategy remains the use of evidence-based central line bundles which have been shown to have substantial impacts on CLABSI rates and their associated morbidity and mortality, as well as costs to the healthcare system. References and recommended reading Papers of particular interest, published within the annual period of review, have been highlighted as: of special interest of outstanding interest Additional references related to this topic can also be found in the Current World Literature section in this issue (pp ). 1 Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in verylow-birthweight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17: Stoll BJ, Hansen NI, Adams-Chapman I, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: Payne NR, Carpenter JH, Badger GJ, et al. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004; 114: Centers for Medicare and Medicaid Services. Press Release 1390: proposed changes to the hospital inpatient prospective payment systems and fiscal year 2009, 14 April O Grady NP, Alexander M, Dellinger EP, et al. Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, Am J Infect Control 1988; 16: Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: Hidron AI, Edwards JR, Patel J, et al. National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, Infect Control Hosp Epidemiol 2008; 29: Edwards JR, Peterson KD, Andrus ML, et al. NHSN Facilities. National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June Am J Infect Control 2007; 35: Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through Am J Infect Control 2009; 37: The most recent publication of healthcare-associated infection benchmark data from the National Healthcare Safety Network. 12 Garland JS, Buck RK, Maloney P, et al. A comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995; 14:
6 90 Infectious diseases and immunization 13 Garland JS, Alex C, Mueller CP, et al. Local reactions to a chlorhexadine gluconate-impregnated antimicrobial dressing in very low birth weight infants. Pediatr Infect Dis J 1996; 15: Curry S, Honeycutt M, Goins G, Gilliam C. Catheter-associated bloodstream infections in the NICU: getting to zero. Neonatal Netw 2009; 28: Garland JS, Alex CP, Uhing MR, et al. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009; 29: The only randomized trial comparing the safety (including systemic absorption) and efficacy of cutaneous antisepsis with chlorhexidine gluconate with povidone iodine in neonatal intensive care unit patients. 16 Garland JS, Alex CP, Sevallius JM, et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol 2008; 29: Miller MR, Griswold M, Harris JM 2nd, et al. Decreasing PICU catheterassociated bloodstream infections: NACHRI s quality transformation efforts. Pediatrics 2010; 125: The first published study from this multicenter national collaborative s efforts to eradicate CLABSIs. 18 Sannoh S, Clones B, Munoz J, et al. A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection. Am J Infect Control 2010; 38: Levy I, Katz J, Solter E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J 2005; 24: Khattak AZ, Ross R, Ngo T, Shoemaker CT. A randomized controlled evaluation of absorption of silver with the use of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines. J Perinatol 2010; 30: Hill ML, Baldwin L, Slaughter JC, et al. A silver alginate-coated dressing to reduce peripherally inserted central catheter (PICC) infections in NICU patients: a pilot randomized controlled trial. J Perinatol 2010; 30: Chelliah A, Heydon KH, Zaoutis TE, et al. Observational trial of antibioticcoated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007; 26: Timsit JF, Schwebel C, Bouadma L, et al., Dressing Study Group. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009; 301: The largest multicenter adult 2 2 factorial study on the use of CHG dressing and less frequent dressing changes to reduce CLABSIs. 24 Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127: Ramritu P, Halton K, Collignon P, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control 2008; 36: Million Lives Campaign. Cambridge, MA: Institute for Healthcare Improvement; [accessed 17 November 2010] This is a great starting point for parties interested in establishing methods to prevent central line infections. 27 Bizzarro MJ, Sabo B, Noonan M, et al. Aqualityimprovementinitiativeto reduce central line associated bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010; 31: Wirtschafter DD, Pettit J, Kurtin P, et al. A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. J Perinatol 2010; 30: A detailed description of the methodology and results from a state-wide collaborative to reduce neonatal CLABSI. 29 Schulman J, Stricof RL, Stevens TP, et al. New York State Regional Perinatal Centers; New York State Department of Health. Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections. J Perinatol 2009; 29: An excellent how to description of the processes involved in identifying a clinical problem and creating a collaborative plan to solve it. 30 Schulman J, Stevens TP, Horgan MJ, et al. Maintenance central line checklist use reduces central line-associated bloodstream infection rates in NICUs, yet NICU site remains an outcome determinant [Abstract]. PAS Bhutta A, Gilliam C, Honeycutt M, et al. Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach. BMJ 2007; 334: Costello JM, Morrow DF, Graham DA, et al. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121: Jeffries HE, Mason W, Brewer M, et al. Prevention of central venous catheterassociated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009; 30:
Implementation Guide for Central Line Associated Blood Stream Infection
Implementation Guide for Central Line Associated Blood Stream Infection March 27, 2013 Contents 1. Introduction... 3 2. Central Line Associated Blood Stream Infection Prevention Evidence-Based Practices...
More informationCatheter-Associated Bloodstream Infections in the NICU: Getting to Zero
Catheter-Associated Bloodstream Infections in the NICU: Getting to Zero Sabra Curry, NNP-BC, MSN, APN Michele Honeycutt, RN, BSN, CIC Gail Goins, RNC Craig Gilliam, BSMT, CIC Reducing catheter-associated
More informationBundle Me Up! Using Central Line Bundles to Decrease Infection
Bundle Me Up! Using Central Line Bundles to Decrease Infection Organization Name: Peninsula Regional : Acute Care Hospital Medical Center Contact Person: Regina Kundell Title: Dir, Women s and Children
More informationDescribe the impact of CLABSI on patients and their families. Discuss three methods of reducing CLABSIs
Describe the impact of CLABSI on patients and their families. Discuss three methods of reducing CLABSIs Explore the essential elements of maintaining decreased CLABSIs 1 2001-43,000 CLABSIs In ICUs 2009-18,000
More informationUsing Care Bundles to Reduce Catheter Associated Blood Stream Infections in the NICU. Dr David Ng Paediatric Medical Officer Sarawak General Hospital
Using Care Bundles to Reduce Catheter Associated Blood Stream Infections in the NICU Dr David Ng Paediatric Medical Officer Sarawak General Hospital Outline of Presentation Introduction Definition of CABSI
More informationAn Educational Intervention to Increase CLABSI Bundle Compliance in the ICU. A thesis presented by. Shelby L. Holden
Shelby Holden 1 An Educational Intervention to Increase CLABSI Bundle Compliance in the ICU A thesis presented by Shelby L. Holden Presented to the College of Education and Health Professions in partial
More information2018 BSI QIA. Kick off Part 1. Annabelle Perez Quality Improvement Director
2018 BSI QIA Kick off Part 1 Annabelle Perez Quality Improvement Director Outline 2018 BSI QIA Overview What does it really mean to follow the CDC Core Interventions Next Steps 2018 BSI QIA Overview BSI
More informationThe Nurse s Role in Preventing CLABSI
The Nurse s Role in Preventing CLABSI This course has been awarded one (1.0) contact hour. This course expires on February 28, 2020 Copyright 2017 by RN.com. All Rights Reserved. Reproduction and distribution
More informationDecreasing Central Line-associated Bloodstream Infections Through Quality Improvement Initiative
R E S E A R C H P A P E R Decreasing Central Line-associated Bloodstream Infections Through Quality Improvement Initiative KALYAN CHAKRAVARTHY BALLA 1, SUMAN PN RAO 1, CELINE ARUL 1, A SHASHIDHAR 1, YN
More informationWHY IMPLEMENT CENTRAL LINE INSERTION BUNDLES
WHY IMPLEMENT CENTRAL LINE INSERTION BUNDLES WHY IMPLEMENT A CENTRAL LINE BUNDLE? Hospital-acquired infections (HAIs) are the fourth largest killer in America. The death toll from HAIs is estimated at
More informationCentral Line Bundle Education. National Patient Safety Goal Preventing Central Line Infections 2010
Central Line Bundle Education National Patient Safety Goal 07.04.01 Preventing Central Line Infections 2010 Central Line Associated Bloodstream Infections CAN and DO kill our patients. THE GOOD NEWS They
More informationMaking Dialysis Safer for Patients Coalition
National Center for Emerging and Zoonotic Infectious Diseases Making Dialysis Safer for Patients Coalition Christi Lines, MPH NANT Symposium February 2017 Outline Introduction to the Coalition Coalition
More informationTranslating Evidence to Safer Care
Translating Evidence to Safer Care Patient Safety Research Introductory Course Session 7 Albert W Wu, MD, MPH Former Senior Adviser, WHO Professor of Health Policy & Management, Johns Hopkins Bloomberg
More informationPrevention of hospital acquired infections do we need more than hand hygiene?
5 th Paediatric Infectious Disease Training Course Prevention of hospital acquired infections do we need more than hand hygiene? Walter Zingg, MD St. Gallen, 25-26 November 2016 5 th Paediatric Infectious
More information2014 Partnership in Prevention Award. November 21, :00-1:00PM EST. Introduction
2014 Partnership in Prevention Award November 21, 2014 12:00-1:00PM EST Introduction Don Wright, MD, MPH Deputy Assistant Secretary for Health (Disease Prevention and Health Promotion) U.S. Department
More informationEpidemiological approach to nosocomial infection surveillance data: the Japanese Nosocomial Infection Surveillance System
Environ Health Prev Med (2008) 13:30 35 DOI 10.1007/s12199-007-0004-y REVIEW Epidemiological approach to nosocomial infection surveillance data: the Japanese Nosocomial Infection Surveillance System Machi
More informationCLABSI: Beyond the Policy and Procedure
CLABSI: Beyond the Policy and Procedure This course has been awarded one (1.0) contact hour. This course expires on July 31, 2017. Copyright 2014 by RN.com. All Rights Reserved. Reproduction and distribution
More informationHealthcare-Associated Infections
Healthcare-Associated Infections A healthcare crisis requiring European leadership Healthcare-associated infections (HAIs - also referred to as nosocomial infections) are defined as an infection occurring
More informationCenters for Disease Control and Prevention (CDC) Patient Hand Hygiene Audit Information and Instructions
Centers for Disease Control and Prevention (CDC) Patient Hand Hygiene Audit Information and Instructions You have agreed to help the Network by doing a very important Hand Hygiene Audit. We thank you for
More informationHospital-Acquired Infections Prevention is in Your Hands. Rachel L. Stricof
Hospital-Acquired Infections Prevention is in Your Hands Rachel L. Stricof rstricof@gmail.com Morbidity 1.7 Million infections per year (estimate 2002) Mortality 99,000 deaths per year (estimate 2002)
More informationBRINGING THE PERIPHERY INTO FOCUS
BRINGING THE PERIPHERY INTO FOCUS RISKS ASSOCIATED WITH PERIPHERAL IVS Russ Olmsted, MPH, CIC, FAPIC Director, Infection Prevention & Control; Trinity Health, Livonia, MI This educational activity is brought
More informationEvidence-based approach to preventing central line-associated bloodstream infection in the NICU
Acta Pædiatrica ISSN 0803 5253 REVIEW ARTICLE Evidence-based approach to preventing central line-associated bloodstream infection in the NICU Timothy P Stevens (timothy_stevens@urmc.rochester.edu) 1, Joseph
More informationAbstract of thesis entitled. An evidence based guideline of using chlorhexidine gluconate impregnated dressing in
Abstract of thesis entitled An evidence based guideline of using chlorhexidine gluconate impregnated dressing in preventing catheter related bloodstream infections in hemato-oncology patients with central
More informationCentral Line Associated Bloodstream Infections: Is achieving zero possible?
Mary-Louise McLaws Professor of Epidemiology Healthcare Associated Infection and Infectious Diseases Control Epidemiology Advisor to Clinical Excellence Commission School of Public Health and Community
More informationNursing Practice for Prevention of Central Line Associated Blood Stream Infection (CLABSI) in A Pediatric Intensive Care Unit
IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 5, Issue 6 Ver. I (Nov. - Dec. 2016), PP 150-154 www.iosrjournals.org Nursing Practice for Prevention
More informationKSENIA ZUKOWSKY, PHD, APRN, NNP-BC Section Editor. Central Line Attention Is Their Best Prevention
KSENIA ZUKOWSKY, PHD, APRN, NNP-BC Section Editor 2.3 HOURS Continuing Education Central Line Attention Is Their Best Prevention Tammy Kime, DNP, NNP-BC, PNP-BC, RN; Khawar Mohsini, MBBS; Martin U. Nwankwo,
More informationSepsis in the NICU and Interventions to Improve Care
Sepsis in the NICU and Interventions to Improve Care Joseph El Khoury, MD Children s Hospital of Richmond at VCU Virginia Neonatal Perinatal Collaborative Meeting May 12 th, 2017 Significance of Sepsis
More informationCMS and NHSN: What s New for Infection Preventionists in 2013
CMS and NHSN: What s New for Infection Preventionists in 2013 Joan Hebden RN, MS, CIC Clinical Program Manager Sentri7 Wolters Kluwer Health - Clinical Solutions Objectives Define the current status of
More information2017 Nicolas E. Davies Enterprise Award of Excellence
2017 Nicolas E. Davies Enterprise Award of Excellence Agenda Memorial Hermann Health System Overview Journey to High Reliability Case study review CLABSI Prevention 2 Memorial Hermann Health System Woodlands
More informationHealth Care Associated Infections in 2015 Acute Care Hospitals
Health Care Associated Infections in 2015 Acute Care Hospitals Alfred DeMaria, M.D. State Epidemiologist Bureau of Infectious Disease and Laboratory Sciences Katherine T. Fillo, Ph.D, RN-BC Quality Improvement
More informationCentral Line-Associated Bloodstream Infection (CLABSI) Event
Central Line-Associated Bloodstream Infection () Event Introduction: An estimated 248,000 bloodstream infections occur in U.S. hospitals each year 1, a large proportion of these are associated with the
More informationJoint Commission NPSG 7: 2011 Update and 2012 Preview
Joint Commission NPSG 7: 2011 Update and 2012 Preview Pharmacy OneSource Webinar June 1, 2011 Louise M. Kuhny, RN, MPH, MBA, CIC The Joint Commission Objectives Upon completion of this program, participants
More informationReducing Infections and Improving Engagement St. Luke's Nephrology Associates. Contact Information: Robert Gayner, M.D., FASN
BEST PRACTICES Vascular Access and CLABSI Reduction Reducing Infections and Improving Engagement St. Luke's Nephrology Associates Contact Information: Robert Gayner, M.D., FASN St. Luke's Nephrology Associates
More informationCENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)
CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) A Step-by- Step Approach 1 Evidence Based Recommendations for the Prevention of CLABSI 2013 CLABSI FACTS An estimated 41,000 central line-associated
More information"Risky Business", Staff -Patient Safety Newsletter
"Risky Business", Staff -Patient Safety Newsletter St. Joseph Medical Center Program/Project Description. When reviewing medication incident report data, we observed that similar errors were occurring
More informationInfection Control: Reducing Hospital Acquired Central Line Bloodstream Infections
The University of San Francisco USF Scholarship: a digital repository @ Gleeson Library Geschke Center Master's Projects and Capstones Theses, Dissertations, Capstones and Projects Spring 5-19-2017 Infection
More informationOutline 1. Infection Prevention Program Bloodborne Pathogens/Exposure Prevention & Management Standard Precautions 2. Hand Hygiene 3. Isolation Precau
Erlanger Infection Prevention Resident and df Fellow Orientation June 2011 1 Outline 1. Infection Prevention Program Bloodborne Pathogens/Exposure Prevention & Management Standard Precautions 2. Hand Hygiene
More informationHAI Peer Learning Network Peer Sharing Event. Topic: CLABSI Prevention. Nov. 28, Place picture here
HAI Peer Learning Network Peer Sharing Event Place picture here Topic: CLABSI Prevention Nov. 28, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Mute your phone during
More informationHRET HIIN MDRO Taking MDRO Prevention to the Next Level!
HRET HIIN MDRO Taking MDRO Prevention to the Next Level! October 17, 2017 12:30 p.m. 1:30 p.m. CT 1 Kristin Preihs Senior Program Manager, HRET WELCOME AND INTRODUCTIONS 2 Webinar Platform Quick Reference
More information1. Nurses may remove non-tunneled catheters upon the order of a physician. Physicians remove tunneled catheters.
Removal of Non-Tunneled Central Venous Catheter (CVC) (Approved Aug 15, 2011/Rev Dec 16, 2011/Rev Jun 13, 2012) Vascular Access Guideline Table of Contents This procedure is posted on the BC Provincial
More informationActionable Patient Safety Solution (APSS) #2F: CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)
Actionable Patient Safety Solution (APSS) #2F: CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) Table of Contents Executive Summary Checklist 2 The Performance Gap 3 Leadership Plan 4 Practice
More informationIs Zero Central Line Associated Bloodstream Infection Rate Sustainable? A 5-Year Perspective
Is Zero Central Line Associated Bloodstream Infection Rate Sustainable? A 5-Year Perspective Carmina Erdei, MD a, Linda L. McAvoy, RN a, Munish Gupta, MD b, Sunita Pereira, MD a, Elisabeth C. McGowan,
More informationNew York State Perinatal Quality Collaborative (NYSPQC): Improving Perinatal Health through Partnerships and Collaboration
New York State Perinatal Quality Collaborative (NYSPQC): Improving Perinatal Health through Partnerships and Collaboration Marilyn Kacica, MD, MPH Kristen Farina, MS New York State Department of Health
More informationReal Time CLABSI Case Reviews at HCMC. Mary Ellen Bennett Steph Laskowski
Real Time CLABSI Case Reviews at HCMC Mary Ellen Bennett Steph Laskowski RCA vs Real Time Case Review Similar: event review with stakeholders, no blame, gives ideas on what could be done better, focus
More informationOverview of CDC s Sepsis Activities
Centers for Disease Control and Prevention Overview of CDC s Sepsis Activities WHO Sepsis Technical Expert Meeting Denise M. Cardo M.D. Director, Division of Healthcare Quality Promotion National Center
More informationHEN 2.0 CLABSI WEBINAR NAILING CLABSI PREVENTION! February 11, :00 a.m. 12:30 p.m. CT
HEN 2.0 CLABSI WEBINAR NAILING CLABSI PREVENTION! February 11, 2016 11:00 a.m. 12:30 p.m. CT 1 WELCOME AND INTRODUCTIONS Kimberly King, Program Specialist, HRET 11:00 11:05 2 WEBINAR PLATFORM QUICK REFERENCE
More informationReducing CLABSI in the NICU with IV Tubing Competency
The University of San Francisco USF Scholarship: a digital repository @ Gleeson Library Geschke Center Master's Projects and Capstones Theses, Dissertations, Capstones and Projects Fall 12-18-2015 Reducing
More informationTHE JOURNEY TO CLINICAL INDICATION: TIME TO MOVE THE NEEDLE
THE JOURNEY TO CLINICAL INDICATION: TIME TO MOVE THE NEEDLE Michelle DeVries, BS, MPH, CIC Senior Infection Preventionist Methodist Hospitals Gary, IN Michelle DeVries is a paid consultant of Ethicon US,
More informationMedical technology guidance Published: 22 July 2015 nice.org.uk/guidance/mtg25
The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites Medical technology guidance Published: 22 July 2015 nice.org.uk/guidance/mtg25 NICE 2015. All rights
More informationConflict of Interest Disclaimer. The Affordable Care Act. The Affordable Care Act. Caring for the Critically Ill. The Affordable Care Act
Conflict of Interest Disclaimer Reducing Risks of Harmful Events in the Critically Ill I have no financial interests or conflicts of interest related to this talk Alfred F. Connors, Jr., MD Chief Medical
More informationPresented by: Mary McGoldrick, MS, RN, CRNI
Infection Prevention and Control Challenges in the Home and Community based Care Mary McGoldrick, MS, RN, CRNI Home Care and Hospice Consultant Saint Simons Island, GA Nothing to Disclose Top 5 Home Care
More information5/9/2015. Disclosures. Improving ICU outcomes and cost-effectiveness. Targets for improvement. A brief overview: ICU care in the United States
Disclosures Improving ICU outcomes and cost-effectiveness CHQI grant, UC Health Travel support, Moore Foundation J. Matthew Aldrich, MD Associate Clinical Professor Interim Director, Critical Care Medicine
More informationAbstract. imedpub Journals Vol.4 No.1:2. Methods. Introduction. N Al-Abdullah * Setting
Research Article imedpub Journals http://www.imedpub.com/ Journal of Intensive and Critical Care DOI: 10.21767/2471-8505.100105 Epidemiology of Central Line-Associated Bloodstream Infection (CLABSI) Among
More informationSee Policy #1302 (Nursing Student Privileges and Limitations) for full details. Central Line dressing care, declotting and discontinuation may ONLY
To assure a standardized knowledge base related to CVL Care and CLABSI prevention, ProMedica requires all Instructors/Faculty on adult and pediatric units to complete this educational module. This content
More informationKey Scientific Publications
Key Scientific Publications Introduction This document provides a list of over 60 key scientific publications for those interested in hand hygiene improvement. For a comprehensive list of pertinent publications,
More informationGetting it Straight to Advance Care of Hospitalized Children: When to Choose Research, Evidencebased Practice or Quality Improvement
Wright State University CORE Scholar College of Nursing and Health Faculty Publications College of Nursing and Health 2-10-2015 Getting it Straight to Advance Care of Hospitalized Children: When to Choose
More informationHealthcare-Associated Infections (HAI) Quality Improvement Activity Project Kickoff Webinar
Healthcare-Associated Infections (HAI) Quality Improvement Activity 2017 Project Kickoff Webinar QIP PY 2019 Final Measure Domain Weighting Domain Weight Measures/Measure Topics Weight (Domain) Safety
More informationInfection Prevention & Control Orientation for Housestaff Welcome to Shands at UF!
Infection Prevention & Control Orientation for Housestaff 2011 Welcome to Shands at UF! Hot Topics: Prevention Initiatives National Patient Safety Goal 07: Prevent Healthcare Associated Infections Prevent
More informationInfection Prevention and Control: How to Meet the Conditions of Participation for Home Health
Infection Prevention and Control: How to Meet the Conditions of Participation for Home Health Mary McGoldrick, MS, RN, CRNI Home Care and Hospice Consultant Saint Simons Island, GA Nothing to Disclose
More informationB.S.N., M.S., CRNI, CNSN
Central Line Infection: Improving our Surveillance, Treatment and Prevention in the Home Setting By Susan Poole, B.S.N., M.S., CRNI, CNSN For as long as patients have had central venous catheters (CVCs),
More informationHospital Acquired Conditions. Tracy Blair MSN, RN
Hospital Acquired Conditions Tracy Blair MSN, RN A hospitalacquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility Hospital
More informationLessons From Infection Prevention Research in Emergency Medicine: Methods and Outcomes
Lessons From Infection Prevention Research in Emergency Medicine: Methods and Outcomes Patricia W. Stone, PhD, RN FAAN Centennial Professor in Health Policy Director PhD Program and Director Center for
More informationLimitations and Guidelines Revised for Elastomeric Devices and IV Supplies and Equipment
Limitations and Guidelines Revised for Elastomeric Devices and IV Supplies and Equipment Information posted January 8, 2007 Effective for dates of service on or after March 1, 2007, benefit limitations
More informationCLABSI Prevention Hardwiring Improvement
CLABSI Prevention Hardwiring Improvement Brian Koll MD, FACP, FIDSA Executive Director, Infection Prevention Mount Sinai Health System Professor of Medicine, Icahn School of Medicine September 29, 2014
More informationNortheast Hospitals Infection Control Policy and Procedure Manual
Northeast Hospitals Infection Control Policy and Procedure Manual Subject: Prevention/Control of Healthcare Associated Infections (HAI) Date Effective: 8/07 Date Revised: 3/11 Key Contact: Infection Prevention
More informationHOSPITAL ACQUIRED COMPLICATIONS. Shruti Scott, DO, MPH Department of Medicine UCI Hospitalist Program
HOSPITAL ACQUIRED COMPLICATIONS Shruti Scott, DO, MPH Department of Medicine UCI Hospitalist Program HOSPITAL ACQUIRED COMPLICATIONS (HACS) A medical condition or complication that a patient develops during
More informationThe impact of nighttime intensivists on medical intensive care unit infection-related indicators
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2016 The impact of nighttime intensivists on medical intensive care unit infection-related indicators Abhaya Trivedi
More informationMaking Evidence-based Clinical Decisions. Paul L. Blackburn, BSN, MNA, RN, VA-BC
Making Evidence-based Clinical Decisions Paul L. Blackburn, BSN, MNA, RN, VA-BC Disclosures Senior Director of Marketing/Education RyMed Technologies President of the Board of Directors Association for
More informationPatient Safety: 10 Years Later Why is Improvement So Hard? Patient Safety: Strong Beginnings
Patient Safety: 10 Years Later Why is Improvement So Hard? G. Ross Baker, Ph.D. Institute of Health Policy, Management & Evaluation University of Toronto 3 November 2014 Patient Safety: Strong Beginnings
More informationAugust 22, Dear Sir or Madam:
August 22, 2012 Office of Disease Prevention and Health Promotion 1101 Wootton Parkway Suite LL100 Rockville, MD 20852 Attention: Draft Phase 3 Long-Term Care Facilities Module Dear Sir or Madam: The Society
More informationKey prevention strategies for MRSA bacteraemia: a case study. Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta
Key prevention strategies for MRSA bacteraemia: a case study Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta 1 Mortality following Staphylococcus aureus bacteraemia
More informationAccreditation Program: Long Term Care
ccreditation Program: Long Term are National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission
More informationBEHAVIORAL HEALTH & LTC. Mary Ann Kellar, RN, MA, CHES, IC March 2011
BEHAVIORAL HEALTH & LTC Mary Ann Kellar, RN, MA, CHES, IC March 2011 CDC Isolation Guidelines-adapting to special environments MDRO s CMS-F 441 C.difficile Norovirus Federal (CMS), State & Joint Commission
More informationSTANDARDIZED PROCEDURE FEMORAL VENOUS BLOOD DRAW (Adult, Peds)
I. Definition The Femoral venous blood draw (FVBD) is the procedure of performing a needle stick into the femoral vein for the purpose of drawing blood work that will assist in lab monitoring. II. Background
More informationReducing Infection Risk At All Access Points
SM 3M Health Care Academy Reducing Infection Risk At All Access Points June 22nd 2016 Corinne SM 3M Health Care Cameron-Watson, Academy RN 3M 2015. All Rights Reserved PORT PROTECTORS IN CLINICAL PRACTICE
More informationHealth Care Associated Infections in 2017 Acute Care Hospitals
Health Care Associated Infections in 2017 Acute Care Hospitals Christina Brandeburg, MPH Epidemiologist Katherine T. Fillo, Ph.D, RN-BC Director of Clinical Quality Improvement Eileen McHale, RN, BSN Healthcare
More informationGlobal Patient Safety Challenge
WHO World Alliance for Patient Safety Global Patient Safety Challenge 2005-2006 Nairobi Durban / January 2005 Professor Didier Pittet, MD, MS, Infection Control Program University of Geneva Hospitals,
More informationChapter 8. Interventions To Improve Hand Hygiene Compliance: Brief Update Review
Chapter 8. Interventions To Improve Hand Hygiene Compliance: Brief Update Review Elizabeth Pfoh, M.P.H.; Sydney Dy, M.D., M.Sc.; Cyrus Engineer, Dr.P.H. Introduction Healthcare-associated infections account
More informationIncreasing CLABSI Bundle Compliance in the NICU
The University of San Francisco USF Scholarship: a digital repository @ Gleeson Library Geschke Center Master's Projects and Capstones Theses, Dissertations, Capstones and Projects Fall 12-14-2017 Increasing
More informationSHEA/APIC Joint Comments on National Action Plan to Prevent Healthcare-Associated Infections: Roadmap to Elimination Phase 2 Revisions
SHEA/APIC Joint Comments on National Action Plan to Prevent Healthcare-Associated Infections: Roadmap to Elimination Phase 2 Revisions End-Stage Renal Disease Facilities Page p. 153 Last paragraph, first
More informationSurveillance Provinciale des Infections Nosocomiales (SPIN) Program: Implementation of a mandatory surveillance program for central lineassociated
Surveillance Provinciale des Infections Nosocomiales (SPIN) Program: Implementation of a mandatory surveillance program for central lineassociated bloodstream infections Patricia S. Fontela, MD, MSc, a
More informationFee: The fee for the 12-month renewal is $10,000.
CHILDHOOD CANCER AND BLOOD DISORDERS NETWORK 2017 RENEWAL TOOLS HOW TO Renew To renew, simply submit a completed Childhood Cancer & Blood Disorders Network Renewal Form to Gena Paulk via email at gena.paulk@childrenshospitals.org.
More informationPROCEDURAL SAFETY CHECKLIST
PROCEDURAL SAFETY CHECKLIST Before any medical or patient care procedure, review checklist together with the other members of the procedural team. This checklist can be used by any health professional
More informationWyoming STATE BOARD OF NURSING
David D. Freudenthal Governor Wyoming STATE BOARD OF NURSING Mary Kay Goetter, PhD, RNC, NEA-BC Executive Director 1810 Pioneer Avenue Cheyenne, Wyoming 82002 Phone: 307-777-7601 FAX: 307-777-3519 http://nursing.state.wy.us
More informationPositive Blood Culture Review Version 7: 6/30/08
Positive Blood Culture Review Version 7: 6/30/08 Name: MR #: DOB: / / Birth WT: GA wk EGA at dx: wk Final Dx: [ ] CABSI [ ] BSI [ ] NEC [ ] VAP [ ] Contaminant [ ] Other: Clinical Findings at Time Blood
More informationPatricia Church, MSN, RN, PCNS-BC, CPON Bernice Mowery, PhD, PNP, RN
Beyond the Bundle: Strategies to Prevent Catheter Related Blood Stream Infections in a Pediatric Oncology In- Patient Unit Patricia Church, MSN, RN, PCNS-BC, CPON Bernice Mowery, PhD, PNP, RN Objectives
More informationSupplementary Online Content
Supplementary Online Content Harris AD, Pineles L, Belton B, Benefits of Universal Glove and Gown (BUGG) investigators. Universal Glove and Gown Use and Acquisition of Antibiotic Resistant Bacteria in
More informationNorth York General Hospital Policy Manual
TITLE: ASEPTIC TECHNIQUE (NON-OPERATING ROOM) CROSS REFERENCE: ORIGINATOR: Manager, IPAC APPROVED BY: Medical Advisory Committee ORIGINAL DATE APPROVED: Dec. 13, 2011 Operations Committee ORIGINAL DATE
More informationSuccessful and Sustained VAP Prevention Patti DeJuilio, MS, RRT-NPS, Manager, Respiratory Care Services, Central DuPage Hospital, Winfield, IL
Successful and Sustained VAP Prevention Patti DeJuilio, MS, RRT-NPS, Manager, Respiratory Care Services, Central DuPage Hospital, Winfield, IL Objectives & About Us Central DuPage Hospital is a large community
More informationHAND WASHING IS THE MOST
ORIGINAL ARTICLE Hand-washing Practices of Facial Plastic Surgeons Douglas D. Leventhal, MD; Leela Lavasani, MD; David Reiter, MD Objectives: (1) To define and characterize knowledge of effective hand
More informationTaking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 3 Strategies to prevent
Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 3 Strategies to prevent Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National
More informationHCA Infection Control Surveillance Survey
HCA Infection Control Surveillance Survey HCA is very interested in reducing nosocomial infections in its hospitals. A key to reducing infections is for each hospital to have a robust infection control
More informationConsumers Union/Safe Patient Project Page 1 of 7
Improving Hospital and Patient Safety: An overview of recently passed legislation and requirements towards improving the safety of California s hospital patients June 2009 Background Since 2006 several
More informationNewborn Nursery/Neonatal Intensive Care Unit
Newborn Nursery/Neonatal Intensive Care Unit Ref:(a) The Association for Professionals in Infection Control and Epidemiology, Principles and Practice, 1996. (b) Hospital Epidemiology and Infection Control,
More informationNew research: Change peripheral intravenous catheters only as clinically
Content page New research: Change peripheral intravenous catheters only as clinically indicated, not routinely. The results of a nurse led and nationally funded multicentre, randomised equivalence trial
More informationLightning Overview: Infection Control
Lightning Overview: Infection Control Gary Preston, PhD, CIC, FSHEA Terry Caton, CIC Carla Ward, CIC 2012 Healthcare Management Alternatives, Inc. Objectives At the end of this module you will know: How
More informationNational Institute for Health and Care Excellence External Assessment Centre correspondence
National Institute for and Care Excellence External Assessment Centre correspondence 3M Tegaderm CHG IV Securement Dressing to provide transparent, antiseptic coverage at central venous and arterial catheter
More informationEvidence-Based Approaches to Hand Hygiene: Best Practices for Collaboration
Evidence-Based Approaches to Hand Hygiene: Best Practices for Collaboration Written by J. Hudson Garrett Jr., PhD, Senior Director, Clinical Affairs, PDI January 09, 2013 Historical perspective Hand hygiene
More informationHealthcare- Associated Infections in North Carolina
2018 Healthcare- Associated Infections in North Carolina Reference Document Revised June 2018 NC Surveillance for Healthcare-Associated and Resistant Pathogens Patient Safety Program NC Department of Health
More informationHealthcare- Associated Infections in North Carolina
2012 Healthcare- Associated Infections in North Carolina Reference Document Revised May 2016 N.C. Surveillance for Healthcare-Associated and Resistant Pathogens Patient Safety Program N.C. Department of
More information